InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

Poland-based AI drug development company Ingenix has raised €13 million [...]

SOTIO Biotech has reported positive preclinical results for SOT106, its [...]

Heidelberg Pharma has reported further clinical activity from its Phase [...]

Axplora has initiated global investments exceeding €100 million in 2025 [...]

Myricx Bio has appointed Boston-based Mohit Rawat as chief executive [...]

Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]